Early steroid withdrawal protocol using basiliximab in kidney transplantation

Transplantation Proceedings

Volumn 36, Issue 2 SUPPL., 2004, Pages S478-S482

  Teraoka, S ^a   Sato, S ^a   Kai, K ^a   Kawase, T ^a   Nakamura, M ^a   Tojinbara, T ^a   Nakajima, I ^a   Fuchinoue, S ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETABOLITE; BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; T LYMPHOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; FEMALE; GENETIC INCOMPATIBILITY; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE CULTURE; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PLASMAPHERESIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TITRIMETRY; TREATMENT OUTCOME;

EID: 1642411012     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.01.063     Document Type: Article

References (13)

1. Tarantino A., Montagnino G., Poticelli C. Corticostroids in kidney transplant recipients safety issues and timing of discontinuation. Drug Safety. 13:1995;145.
2. Sanfey H., Haussman G., Issacs I., et al. Steroid withdrawal in kidney transplant recipients is it a safe option? Clin Transpl. 11:1997;500.
3. Mathew T.H. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation results at three years. Transplantation. 65:1998;1450.
4. Kasiske B.L., Chakkera H.A., Ma J.Z., et al. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol. 11:2000;1910.
5. Sawada T., Fuchinoue S., Teraoka S. Successful A-1-to O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD2-monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis. Transplantation. 74:2002;1207.
6. Opelz G. Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure the collaborative transplant study. Kidney Intern. 52:(suppl):1995;89.
7. Gomez E., Laures A., Navascues R., et al. Steroid withdrawal in renal transplantation treated with cyclosporine A long-term evolution. Transplant Proc. 33:2001;3263.
8. Boots J.M., Christians M.H., van Hooff J.P., et al. Early steroid withdrawal in renal transplantation with tacrolimus dual therapy a pilot study. Clin Transpl. 74:2002;1703.
9. Dum T.B., Asolati M., Holman D.M., et al. Long-term outcome of a prospective trial of steroid withdrawal after kidney transplantation. Surgery. 125:1999;155.
10. Ratcliffe P.J., Dadley C.R.K., Morris P.J., et al. Randomized controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet. 348:1996;643.
11. Miyahara C., Hori S., Teraoka S., et al. Ocular complications following renal transplantation. Jpn J Clin Ophthalmol. 53:1999;1355.
12. Pascual M., Theruvath T., Cosimi A.B., et al. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med. 346:2002;580.
13. Montagnino G., Tarantino A., Ponticelli C., et al. Long-term results of a randomized study comparing three immunosuppressive schedules with cyclosporine in cadaveric kidney transplantation. J Am Soc Nephrol. 12:2001;2163.